Synthesis and cytotoxicity of a biotinylated CC-1065 analogue

BMC Chemical Biology

Volumn 2, Issue , 2002, Pages 1-4

  Wang, Yuqiang ^a   Yuan, Huiling ^a   Wright, Susan C ^a   Wang, Hong ^a   Larrick, James W ^a  

^a Panorama Research Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AVIDIN; RACHELMYCIN; STREPTAVIDIN;

ANTIBODY BLOOD LEVEL; APOPTOSIS; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOLECULAR DYNAMICS;

EID: 0012918049     PISSN: 14726769     EISSN: None     Source Type: Journal    
DOI: 10.1186/1472-6769-2-1     Document Type: Article

References (30)

1. Hnatowich DJ, Virzi F, Rusckowski M: Investigations of avidin and biotin for imaging applications. J Nucl Med 1987, 28:1294-1302
2. Paganelli G, Pervez S, Siccardi AG, Rowlinson G, Deleide G, Chiolerio F, Malcovati M, Scassellati GA, Epenetos AA: Intraperitoneal radiolocalization of tumors pre-targeted by biotinylated monoclonal antibodies. Int J Cancer 1990, 45:1184-1189
3. Axworthy DB, Fritaberg AR, Hylarides MD, Mallet R, Theodore LJ, Gustavson LM, Su FM, Beamuier PL, Reno JM: Durable complete remissions of breast, lung, and colon tumor xenografts with a single dose of pretargeted Y-90 in a mouse model. J Nucl Med 1995, 36:217P
4. Stoldt HS, Aftab F, Chinol M, Paganelli G, Luca F, Testori A, Geraghty JG: Pretargeting strategies for radio-immunoguided tumour localisation and therapy. Eur J Cancer 1997, 33:186-192
5. Knox SJ, Goris ML, Tempero M, Weiden PL, Gentner L, Breitz H, Adams GP, Axworthy D, Gaffigan S, Bryan K, Fisher DR, Colcher D, Horak ID, Weiner LM: Phase II trial of Yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer. Clin Cancer Res 2000, 6:406-414
6. Gautherot E, Rouvier E, Daniel L, Loucif E, Bouhou J, Manetti C, Martin M, Le Doussal JM, Barbet J: Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 1311-labeled bivalent hapten. J Nucl Med 2000, 41:480-487
7. Green NM: Avidin. Adv Protein Chem 1975, 29:85-133
8. Green NM: Avidin and streptavidin. Methods Enzymol 1990, 184:51-67
9. Hanka LJ, Dietz A, Gerpheide SA, Kuentzel SL, Martin DG: CC-1065 (NSC-218223), A new antitumor antibiotic. Production, in vitro biological activity, microbiological assays, and taxonomy of the producing microorganisms. J Antibiot 1978, 31:1211-1217
10. Martin DG, Chidester CG, Duchamp DJ, Mizsak SA: Structure of CC-1065 (NSC-218223), a new antitumor antibiotic. J Antibiot 1980, 33:902-903
11. Martin DG, Biles C, Gerpheide SA, Hanka LJ, Kroeger WC, McGovern JP, Mizsk SA, Neil GL, Stewart JC, Visser J: CC-1065 (NSC-218223), a potent new antitumor agent, improved production and isolation, characterization and antitumor activity. J Antibiot 1981, 34:1119-1125
12. Bhuyan BK, Newell KA, Crampton SL, Von Hoff DD: CC-1065 (NSC-218223), a most potent antitumor agent: Kinetics of inhibition of growth, DNA synthesis and cell survival. Cancer Res 1982, 42:3532-3537
13. Swenson DH., Li LH, Hurley LH, Rokem JS, Petzold GL, Dayton BD, Wallace TL, Lin AH, Krueger WK: Mechanism of interaction of CC-1065 (NSC-218223) with DNA. Cancer Res 1982, 42:2821-2828
14. Hurley LH, Reynolds VL, Swenson DH, Petzold GL, Scahill TA: Reaction of the antitumor antibiotics CC-1065 with DNA: Structure of a DNA adduct with DNA sequence specificity. Science 1984, 226:843-844
15. Reynolds VL, Molineaux IJ, Kaplan DJ, Swenson DH, Hurley LH: Reaction of antitumor antibiotic CC-1065 with DNA. Location of the site of thermally induced strand breakage and analysis of DNA sequence specificity. Biochemistry 1985, 27:6228-6237
16. Chiang SY, Welch J, Rauscher III FJ, Beerman TA: Effects of minor groove binding drugs on the interaction of TATA box binding protein and TFIIA with DNA. Biochemistry 1994, 33:7033-7040
17. McGovren JP, Clarke GL, Pratt EA, DeKoning TF: Preliminary toxicity studies with the DNA-binding antibiotic CC-1065. J Antibiot 1984, 37:63-70
18. Aristoff PA: CC-1065 Analogs: Sequence Specific DNA-alkylating Antitumor Agents. Adv Med Chem 1993, 2:67-110
19. (b) Boger DL, Boyce C. W, Garbaccio RM, Goldberg JA:CC-1065 and the Duocarmycins: Synthetic Studies. Chem Rev 1997, 97:787-820, and references cited
20. Wang Y, Wright SC, Larrick JW: DNA-binding indole derivatives, their prodrugs and immunoconjugates, U. S. Patent US 5,843,937, 1998
21. Boger DL, Santillán A Jr, Searcey M, Jin Q: Critical role of the linking amide in CC-1065 and the duocarmycins: implications on the source of DNA alkylation catalysis. J Am Chem Soc 1998, 120:11554-11557
22. Fukuda Y, Seto S, Furuta H, Ebisu H, Oomori Y, Terashima S: The novel cyclopropapyrroloindole (CPI) bis-alkylators bearing 3,3′-(1,4-phenylene) diacryloyl group as a linker. Bioorg Med Chem Lett 1998, 8:2003-2004
23. Boger DL, Turnbull P: Synthesis and evaluation of a carbocyclic analogue of the CC-1065 and duocarmycin alkylation subunit: Role of the vinylogous amide and implications on DNA alkylation catalysis. J Org Chem 1998, 63:8004-8011
24. Boger DL, Santillán A Jr, Searcey M, Jin Q: Synthesis and evaluation of duocarmycin and CC-1065 analogues containing modifications in the subunit linking amide. J Org Chem 1999, 64:5241-5244
25. Milbank JBJ, Tercel M, Atwell GJ, Wilson WR, Hogg A, Denny WA: Synthesis of 1-substituted 3-(chloromethyl)-6-aminoindoline (6-amino-seco-CI) DNA minor groove alkylating agents and structure-activity relationships for their cytotoxicity. J Med Chem 1999, 42:649-658
26. Boger DL, Stauffer F, Hedrick MP: Substituent effects within the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065. Bioorg Med Chem Lett 2001, 11:2021-2024
27. Wang Y, Yuan H, Ye W, Wright SC, Wang H, Larrick JW: Synthesis and Preliminary Biological Evaluations of CC-1065 Analogs: Effects of Different Linkers and Terminal Amides on Biological Activity. J Med Chem 2000, 43:1541-1549
28. Aristoff PA, Johnson PD: Synthesis of CBI-PDE-1-dimer, the benzannelated analogue of CC-1065. J Org Chem 1992, 57:6234-6239
29. Wrasidlo W, Johnson DS, Boger DL: Induction of endonucleolytic DNA fragmentation and apoptosis by the duocarmycins. Bioorg Med Chem 1994, 4:631-636
30. Wright SC, Schellenberger U, Wang H, Wang Y, Kinder DH: Chemotherapeutic drug activation of the AP24 protease in apoptosis: Requirement for caspase 3-like proteases. Biochem Biophys Res Commun 1998, 245:797-803